Search research articles
Contact Us
Filters
Showing results (721-730 of 764) with videos related to
Page
of 77
Sort By:
Cardiovascular Diabetology
|
February 27, 2020
The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety
Charles E Leonard, Colleen M Brensinger, Ghadeer K Dawwas, et al.
Harm Reduction Journal
|
July 14, 2024
Assessing experts' perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State
Daniel J Kruger, Hilary M Kirk, Kenneth E Leonard, et al.
British Journal of Clinical Pharmacology
|
May 13, 2022
Skeletal muscle relaxant drug-drug-drug interactions and unintentional traumatic injury: Screening to detect three-way drug interaction signals
Cheng Chen, Sean Hennessy, Colleen M Brensinger, et al.
American Journal of Epidemiology
|
October 9, 2025
Identifying observable medication use time in administrative databases: A tutorial using nursing home residents
Daniel A Harris, Adam D'Amico, Hemalkumar B Mehta, et al.
Clinical Pharmacology and Therapeutics
|
July 26, 2022
Identifying Clinically Relevant Drug-Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection
Todd A Miano, Lei Wang, Charles E Leonard, et al.
Clinical Pharmacology and Therapeutics
|
July 15, 2016
Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association
J J Gagne, X Han, S Hennessy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors
Amita Patnaik, Glen J Weiss, John E Leonard, et al.
Journal of Thrombosis and Thrombolysis
|
November 24, 2021
Self-controlled assessment of thromboembolic event (TEE) risk following intravenous immune globulin (IGIV) in the U.S. (2006-2012)
Eric M Ammann, Elizabeth A Chrischilles, Ryan M Carnahan, et al.
Journal of Psychiatric Research
|
May 8, 2022
Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injury
Thanh Phuong Pham Nguyen, Samantha E Soprano, Sean Hennessy, et al.
Cancer Medicine
|
September 1, 2021
A prospective Phase III trial evaluating patient self-reported pain and cosmesis in accelerated partial breast irradiation utilizing 3-D versus intensity-modulated radiotherapy
Charles E Leonard, Yunfei Wang, Lina Asmar, et al.
Page
of 77
Search research articles
Search
Showing results (721-730 of 764) with videos related to
Sort By:
Page
of 77
Cardiovascular Diabetology
|
February 27, 2020
The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety
Charles E Leonard, Colleen M Brensinger, Ghadeer K Dawwas, et al.
Harm Reduction Journal
|
July 14, 2024
Assessing experts' perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State
Daniel J Kruger, Hilary M Kirk, Kenneth E Leonard, et al.
British Journal of Clinical Pharmacology
|
May 13, 2022
Skeletal muscle relaxant drug-drug-drug interactions and unintentional traumatic injury: Screening to detect three-way drug interaction signals
Cheng Chen, Sean Hennessy, Colleen M Brensinger, et al.
American Journal of Epidemiology
|
October 9, 2025
Identifying observable medication use time in administrative databases: A tutorial using nursing home residents
Daniel A Harris, Adam D'Amico, Hemalkumar B Mehta, et al.
Clinical Pharmacology and Therapeutics
|
July 26, 2022
Identifying Clinically Relevant Drug-Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection
Todd A Miano, Lei Wang, Charles E Leonard, et al.
Clinical Pharmacology and Therapeutics
|
July 15, 2016
Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association
J J Gagne, X Han, S Hennessy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors
Amita Patnaik, Glen J Weiss, John E Leonard, et al.
Journal of Thrombosis and Thrombolysis
|
November 24, 2021
Self-controlled assessment of thromboembolic event (TEE) risk following intravenous immune globulin (IGIV) in the U.S. (2006-2012)
Eric M Ammann, Elizabeth A Chrischilles, Ryan M Carnahan, et al.
Journal of Psychiatric Research
|
May 8, 2022
Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injury
Thanh Phuong Pham Nguyen, Samantha E Soprano, Sean Hennessy, et al.
Cancer Medicine
|
September 1, 2021
A prospective Phase III trial evaluating patient self-reported pain and cosmesis in accelerated partial breast irradiation utilizing 3-D versus intensity-modulated radiotherapy
Charles E Leonard, Yunfei Wang, Lina Asmar, et al.
Page
of 77